Established in Finland, this Manufacturer is a premier CTD dossier owner and manufacturer, renowned for producing over 200 high-quality food supplements. Specializing as a CTD dossier owner and manufacturer, they offer a variety of products, including vitamins, minerals, and special supplements in forms such as tablets, capsules, and liquids. As a GMP manufacturer, they ensure all products meet stringent quality standards, solidifying their reputation as a dependable CTD dossier owner and manufacturer. Their innovative approach to product development has made them a key player in the market, providing versatile health solutions as a CTD dossier owner and manufacturer. Products crafted by this Manufacturer are available globally, demonstrating their extensive reach and commitment to quality as a GMP manufacturer.

The company, founded in 1992, has a strong foundation in pharmaceutical production and regulatory affairs, initially supporting third-party companies in the registration of generic medicines in Italy. Over time, this CTD dossier owner and manufacturer developed a focus on probiotic-based products, recognizing the therapeutic potential of probiotic lactic bacteria and their derivatives as safe, low-impact alternatives for health and well-being. In 2000, it launched the first medicine based on probiotic strains for women's health, leading to a broader range of biotherapeutic products. The company has its own research and development facilities and a GMP-certified production plant, reflecting its commitment to innovation, quality, and reliability in therapeutic solutions.

The company, founded in 1992, has a strong foundation in pharmaceutical production and regulatory affairs, initially supporting third-party companies in the registration of generic medicines in Italy. Over time, this CTD dossier owner and manufacturer developed a focus on probiotic-based products, recognizing the therapeutic potential of probiotic lactic bacteria and their derivatives as safe, low-impact alternatives for health and well-being. In 2000, it launched the first medicine based on probiotic strains for women's health, leading to a broader range of biotherapeutic products. The company has its own research and development facilities and a GMP-certified production plant, reflecting its commitment to innovation, quality, and reliability in therapeutic solutions.